论文信息 - O011/#496 Mirvetuximab soravtansine and bevacizumab in folate receptor αlpha-positive ovarian cancer: efficacy in patients with and without prior bevacizumab - 字舞流文

O011/#496 Mirvetuximab soravtansine and bevacizumab in folate receptor αlpha-positive ovarian cancer: efficacy in patients with and without prior bevacizumab

Cesar M. Castro | D. Provencher | S. Memarzadeh | U. Matulonis | Jiuzhou Wang | M. Method | G. Mantia-Smaldone | A. Oaknin | D. O’Malley | L. Gilbert | P. Lim | B. Esteves | K. Moore